Overview

Sugammadex and Smoker's Neuromuscular Block

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
We compared the durations of antagonizing and of the severity of effect of sugammadex used in antagonizing the rocuronium in smoker and non-smoker total 40 patients with using Train of Four(TOF) neuromuscular monitorization.
Phase:
Phase 4
Details
Lead Sponsor:
Duzce University